医薬品受託製造・受託研究の世界市場分析:サービス別(CMO {API /バルク薬物、先端薬物送達完成製剤}}、CRO {腫瘍学、ワクチン、免疫学、心臓学、神経科学})、セグメント予測、2014-2025

【英語タイトル】Pharmaceutical Contract Manufacturing & Contract Research Market By Services (CMO {API/Bulk Drugs, Advanced Drug Delivery Finished Dose Formulations}, CRO {Oncology, Vaccines, Immunology Cardiology, Neuroscience}), & Segment Forecasts, 2014-2025

Grand View Researchが出版した調査資料(GVIEW707653)・商品コード:GVIEW707653
・発行会社(調査会社):Grand View Research
・発行日:2017年5月17日
・ページ数:180
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥559,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,124,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、医薬品受託製造・受託研究の世界市場について調査・分析し、医薬品受託製造・受託研究の世界市場動向、医薬品受託製造・受託研究の世界市場規模、市場予測、セグメント別医薬品受託製造・受託研究市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global pharmaceutical contract manufacturing/contract research market is anticipated to reach USD 238.3 billion by 2025, according to a new report by Grand View Research, Inc. Impact on the volume of capacity that is required for production due to of increasing expression levels is anticipated to influence outsourcing industry. Increased cell densities as well as increase in expression of each cell has led to the steady decline in the volume requirement. The aforementioned fact provides the client with choices for in selection from several CMOs, which was not the fact earlier. The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful departure from the procurement-based outsourcing. This was one of the many approaches that the service industry had become accustomed to.
Expanding market for biosimilars and biobetters is anticipated to pronounce the demand for contract development and manufacturing support. Service providers that hold the potential of providing cost as well as quality advantages are set to make inroads and grow at tremendous pace in the forecast period.
However, as drug manufacturers are increasing the investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers thereby hampering industrial growth.
Further Key Findings from the Report Suggest:
• Contract manufacturing services estimated to dominate the market over research services
• These services are segmented on the basis of development of different forms of formulations. Active Pharmaceutical Ingredient (API) / Bulk drugs registered the largest share of revenue.
• Pharmaceutical companies prefer the outsourcing services for API research and manufacture
• Factors supportive for this trend includes reduction in the cost of production of APIs
• Active molecules from small companies are always acquired by the big pharmaceutical companies
• The prominent entities focus on marketing rather than core competencies of production of API in order to maintain presence
• Finished dose formulations are expected to register the fastest growth in the coming years
• Contract research services for oncology dominated the market and are anticipated to maintain the dominance in the coming years
• CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive growth
• Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years
• The major countries include Brazil. Russia, India, and China as the contract service sector is in its infancy in these regions
• Key players contributing in this market are AbbVie Contract Manufacturing, Catalent, Grifols International, S.A., Baxter BioPharma Solutions, Boehringer Ingelheim Biopharmaceuticals Gmbh, Dalton Pharma Services, and Patheon.
• Companies are engaged in lifecycle management of small-molecule drugs through the development of modified generics with uniquely enhanced properties
• Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth

【レポートの目次】

Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Pharmaceutical Contract Manufacturing/Contract Research Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Drug shortage leading to drive demand for pharmaceutical development
3.1.1.2 Commercial success of biologics for clinical use
3.1.1.3 Lower manufacturing costs and improving economic condition of BRIC
3.1.2 Market restraint analysis
3.1.2.1 Limited outsourcing among big pharma companies’ clients
3.1.2.2 Regulatory issues pertaining to the drug approval
3.2 Penetration &Growth Prospect Mapping, 2016
3.3 Pharmaceutical Contract Manufacturing & Research Services – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Pharmaceutical Contract Manufacturing/Contract Research Market Categorization: Service Estimates & Trend Analysis
4.1 Pharmaceutical contract manufacturing & research servicesmarket: Service movement analysis
4.2 Manufacturing
4.2.1 Contract manufacturing services market, 2014 – 2025 (USD Billion)
4.2.2 API/bulk drugs
4.2.2.1 API/bulk drugs contract manufacturing market, 2014 – 2025 (USD Billion)
4.2.3 Advanced drug delivery formulations contract manufacturing
4.2.3.1 Advanced drug delivery formulations contract manufacturing services market, 2014 – 2025 (USD Billion)
4.2.4 Packaging
4.2.4.1 Packaging contract services market, 2014 – 2025 (USD Billion)
4.2.5 Finished dose formulations contract manufacturing
4.2.5.1 Finished dose formulations contract manufacturing market, 2014 – 2025 (USD Billion)
4.2.5.2 Solid finished dose formulations contract manufacturing
4.2.5.2.1 Solid finished dose formulations contract manufacturing market, 2014 – 2025 (USD Billion)
4.2.5.3 Liquid formulations
4.2.5.3.1 Liquid formulations contract manufacturing market, 2014 – 2025 (USD Billion)
4.2.5.4 Semi-solid formulations contract manufacturing
4.2.5.4.1 Semi-solid formulations contract manufacturing market, 2014 – 2025 (USD Billion)
4.3 Research
4.3.1 Research services market, 2014 – 2025 (USD Billion)
4.3.2 Oncology
4.3.2.1 Oncology market, 2014 – 2025 (USD Billion)
4.3.3 Vaccines
4.3.3.1 Vaccines market, 2014 – 2025 (USD Billion)
4.3.4 Inflammation & immunology
4.3.4.1 Inflammation & immunology market, 2014 – 2025 (USD Billion)
4.3.5 Cardiology
4.3.5.1 Cardiology market, 2014 – 2025 (USD Billion)
4.3.6 Neuroscience
4.3.6.1 Neuroscience market, 2014 – 2025 (USD Billion)
4.3.7 Other
4.3.7.1 Other research services market, 2014 – 2025 (USD Billion)
Chapter 5 Pharmaceutical Contract Manufacturing/Contract Research Market Categorization: Country Estimates & Trend Analysis, by Service
5.1 Global Pharmaceutical Contract Manufacturing/Contract Research Market Share By Country, 2016& 2025
5.2 North America
5.2.1 North America pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.2.2 U.S.
5.2.2.1 U.S. pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.2.3 Canada
5.2.3.1 Canada pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.3 Europe
5.3.1 Europe pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.3.2 Germany
5.3.2.1 Germany pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.3.3 UK
5.3.3.1 UK pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.4 Asia Pacific
5.4.1 Asia Pacific pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.4.2 India
5.4.2.1 India pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.4.3 China
5.4.3.1 China pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.5 Latin America
5.5.1 Latin America pharmaceutical contract manufacturing market, 2014 – 2025 (USD Billion)
5.5.2 Brazil
5.5.2.1 Brazil pharmaceutical contract manufacturing market, 2014 – 2025 (USD Billion)
5.5.3 Mexico
5.5.3.1 Mexico pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.5.4 Colombia
5.5.4.1 Colombia pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.5.5 Argentina
5.5.5.1 Argentina pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.5.6 Chile
5.5.6.1 Chile pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.5.7 Venezuela
5.5.7.1 Venezuela pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.6 MEA
5.6.1 MEA pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
5.6.2 South Africa
5.6.2.1 South Africa pharmaceutical contract manufacturing & research services market, 2014 – 2025 (USD Billion)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Boehringer Ingelheim GmbH
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Lonza
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Grifols S.A
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Jubilant Life Sciences Limited
6.3.4.1 Company overview
6.3.4.2 Financial Performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Pfizer, Inc. (Pfizer CenterOne)
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Charles River Laboratories International, Inc.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Albany Molecular Research, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Covance, Inc. (LabCorp)
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 QuintilesIMS
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 Baxter BioPharma Solutions
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Aenova Holding GmbH
6.3.11.1 Company Overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 Vetter Pharma
6.3.12.1 Company Overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Valeant Pharmaceuticals International Inc.
6.3.13.1 Company Overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.14 Ligand Pharmaceuticals, Inc.
6.3.14.1 Company Overview
6.3.14.2 Financial performance
6.3.14.3 Product benchmarking
6.3.14.4 Strategic initiatives
6.3.15 Pharmaceutical Product Development, LLC
6.3.15.1 Company Overview
6.3.15.2 Financial performance
6.3.15.3 Product benchmarking
6.3.15.4 Strategic initiatives
6.3.16 Recipharm AB.
6.3.16.1 Company Overview
6.3.16.2 Financial performance
6.3.16.3 Product benchmarking
6.3.16.4 Strategic initiatives
6.3.17 AbbVie, Inc.
6.3.17.1 Company Overview
6.3.17.2 Financial performance
6.3.17.3 Product benchmarking
6.3.17.4 Strategic initiatives
6.3.18 Famar Health Care Services
6.3.18.1 Company Overview
6.3.18.2 Financial performance
6.3.18.3 Product benchmarking
6.3.18.4 Strategic initiatives
6.3.19 Catalent Pharma Solutions
6.3.19.1 Company Overview
6.3.19.2 Financial performance
6.3.19.3 Product benchmarking
6.3.19.4 Strategic initiatives
6.3.20 West Pharmaceutical Services, Inc.
6.3.20.1 Company Overview
6.3.20.2 Financial performance
6.3.20.3 Product benchmarking
6.3.20.4 Strategic initiatives

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Factors playing role in drug shortfall
FIG. 12 Market restraint relevance analysis (current & future impact)
FIG. 13 Penetration & growth prospect mapping, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Pharmaceutical Contract Manufacturing/Contract Research:Service outlook key takeaways
FIG. 17 Top five activities by average percentage of activity outsourced
FIG. 18 Pharmaceutical Contract Manufacturing/Contract Research: Service movement analysis
FIG. 19 Survey study for outsourcing needs
FIG. 20 Contract manufacturing & research services market, 2014 - 2025 (USD Billion)
FIG. 21 API/bulk drugs contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 22 Advanced drug delivery formulations market, 2014 - 2025 (USD Billion)
FIG. 23 Packaging contract services market, 2014 - 2025 (USD Billion)
FIG. 24 Finished dose formulations market, 2014 - 2025 (USD Billion)
FIG. 25 Solid finished dose formulations contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 26 Liquid formulations contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 27 Semi-solid formulations contract manufacturing market, 2014 - 2025 (USD Billion)
FIG. 28 Contract research services market, 2014 - 2025 (USD Billion)
FIG. 29 Oncology market, 2014 - 2025 (USD Billion)
FIG. 30 Breakdown of vaccines on the basis of availability
FIG. 31 Vaccines market, 2014 - 2025 (USD Billion)
FIG. 32 Inflammation & immunology market, 2014 - 2025 (USD Billion)
FIG. 33 Cardiology market, 2014 - 2025 (USD Billion)
FIG. 34 Neuroscience market, 2014 - 2025 (USD Billion)
FIG. 35 Other research services market, 2014 - 2025 (USD Billion)
FIG. 36 Regional market place: Key takeaway
FIG. 37 Global Pharmaceutical Contract Manufacturing/Contract Research country outlook, 2016 & 2025
FIG. 38 North America Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 39 U.S. Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 40 Canada Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 41 Europe Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 42 Germany Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 43 UK Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 44 Asia Pacific Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 45 India Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 46 China Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 47 Latin America Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 48 Brazil Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 49 Mexico Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 50 Colombia Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 51 Argentina Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 52 Chile Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 53 Venezuela Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 54 MEA Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 55 South Africa Pharmaceutical Contract Manufacturing/Contract Research Market, 2014 - 2025 (USD Billion)
FIG. 56 Strategy framework
FIG. 57 Participant categorization


List of Tables
TABLE 1 North America Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 2 North America manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 3 North America finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 4 North America research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 5 North America oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 6 U.S. Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 7 U.S. manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 8 U.S. finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 9 U.S. research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 10 U.S. oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 11 Canada Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 12 Canada manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 13 Canada finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 14 Canada research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 15 Canada oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 16 Europe Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 17 Europe manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 18 Europe finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 19 Europe research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 20 Europe oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 21 Germany Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 22 Germany manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 23 Germany finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 24 Germany research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 25 Germany. oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 26 UK Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 27 UK manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 28 UK finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 29 UK research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 30 UK oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 31 Asia Pacific Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 32 Asia Pacific manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 33 Asia Pacific finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 34 Asia Pacific research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 35 Asia Pacific oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 36 India Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 37 India manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 38 India finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 39 India research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 40 India. oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 41 China Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 42 China manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 43 China finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 44 China research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 45 China oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 46 Latin America Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 47 Latin America manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 48 Latin America finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 49 Latin America research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 50 Latin America oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 51 Brazil Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 52 Brazil manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 53 Brazil finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 54 Brazil research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 55 Brazil oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 56 Mexico Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 57 Mexico manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 58 Mexico finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 59 Mexico research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 60 Mexico oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 61 Colombia Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 62 Colombia manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 63 Colombia finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 64 Colombia research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 65 Colombia oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 66 Argentina Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 67 Argentina manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 68 Argentina finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 69 Argentina research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 70 Argentina oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 71 Chile Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 72 Chile manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 73 Chile finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 74 Chile research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 75 Chile oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 76 Venezuela Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 77 Venezuela manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 78 Venezuela finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 79 Venezuela research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 80 Venezuela oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 81 MEA Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 82 MEA manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 83 MEA finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 84 MEA research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 85 MEA oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)
TABLE 86 South Africa Pharmaceutical Contract Manufacturing/Contract Research Market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 87 South Africa manufacturing & research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 88 South Africa finished dose formulations market forecasts, by service, 2016 - 2025 (USD Billion)
TABLE 89 South Africa research services market forecasts, by services, 2016 - 2025 (USD Billion)
TABLE 90 South Africa oral mouth rinse contract manufacturing, by brands (USD Billion, 2014 - 2025)


★調査レポート[医薬品受託製造・受託研究の世界市場分析:サービス別(CMO {API /バルク薬物、先端薬物送達完成製剤}}、CRO {腫瘍学、ワクチン、免疫学、心臓学、神経科学})、セグメント予測、2014-2025] (コード:GVIEW707653)販売に関する免責事項を必ずご確認ください。
★調査レポート[医薬品受託製造・受託研究の世界市場分析:サービス別(CMO {API /バルク薬物、先端薬物送達完成製剤}}、CRO {腫瘍学、ワクチン、免疫学、心臓学、神経科学})、セグメント予測、2014-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆